| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | BLOOD REVIEWS LetPub Score 7.7
50 ratings
Rate
Reputation 8.8 Influence 6.5 Speed 9.1 | ||||||||||||||||||||
| 期刊簡稱 | BLOOD REV | ||||||||||||||||||||
| ISSN | 0268-960X | ||||||||||||||||||||
| E-ISSN | 1532-1681 | ||||||||||||||||||||
| h-index | 85 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 1.40%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.bloodreviews.com/ | ||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/BLOODREVIEWS | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Churchill Livingstone | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||
| 創刊年 | 1987 | ||||||||||||||||||||
| 每年文章數 | 82每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 27.59% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0268-960X%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [BLOOD REVIEWS] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 21:58:59 評論於 Every study is inevitably limited by research limitations. Factors such as research design and research methods may contribute to research limitations  (0) 讚！ | 维尔娜菲茨杰拉德  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 11:44:51 評論於 It is still necessary to clearly state the limitations of the research in the paper and explain how these limitations impact the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the study. Discussing the limitations of the research work in the discussion section generally enhances the credibility of the article. Thinking about how to overcome these limitations in future research will have a positive effect. ### (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 21:08:16 評論於 Do we need to clarify the limitations of the article in discussions? (0) 讚！ | 龙鳞孝礼 |
| 作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 14:38:22 評論於 What are the limitations of this article? (0) 讚！ | Darlene Pepys |
| 作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2019-10-25 12:44:15 評論於 Looking for experience and sharing (0) 讚！ | Oliver Jerry |
| 作者: Uldwyna 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-23 17:53:27 評論於 This journal is difficult to send, not a high-quality article is basically a second rejection. (0) 讚！ | Uldwyna |
| 作者: Horace Mike 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-23 11:00:26 評論於 This journal is very difficult to publish in. Articles that are not of high quality are basically rejected immediately (0) 讚！ | Horace Mike |
| 作者: 梦岚大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2016-05-05 20:09:20 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: Commissioned by the end of 2014, due to personal reasons during the period delaying for a long time, the editor was very nice, waiting for me for nearly 6 months after sending an email for leave. Submitted in October 2015, received feedback after 2 months, with opinions from four experts. List out the issues of the article one by one, revised and uploaded the revision by the end of February 2016, with an additional figure. Response to reviewers received in 1.5 months. No minor revisions. The journal is very rigorous and has high requirements (0) 讚！ | 梦岚大叔 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
